Afya Limited $AFYA Shares Sold by Renaissance Technologies LLC

Renaissance Technologies LLC lessened its stake in Afya Limited (NASDAQ:AFYA) by 15.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 379,000 shares of the company’s stock after selling 67,100 shares during the period. Renaissance Technologies LLC owned about 0.40% of Afya worth $5,636,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in AFYA. Swedbank AB increased its holdings in shares of Afya by 170.3% during the 4th quarter. Swedbank AB now owns 189,200 shares of the company’s stock valued at $2,916,000 after purchasing an additional 119,200 shares in the last quarter. State Street Corp boosted its holdings in Afya by 25.8% during the fourth quarter. State Street Corp now owns 126,914 shares of the company’s stock worth $1,955,000 after buying an additional 26,005 shares in the last quarter. Bank of America Corp DE grew its position in Afya by 11.9% during the second quarter. Bank of America Corp DE now owns 86,201 shares of the company’s stock valued at $1,540,000 after buying an additional 9,192 shares during the period. Arrowstreet Capital Limited Partnership grew its position in Afya by 5.6% during the second quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company’s stock valued at $1,217,000 after buying an additional 3,626 shares during the period. Finally, Geode Capital Management LLC increased its holdings in Afya by 16.6% in the fourth quarter. Geode Capital Management LLC now owns 60,378 shares of the company’s stock valued at $930,000 after buying an additional 8,610 shares in the last quarter. Institutional investors and hedge funds own 88.02% of the company’s stock.

Afya Price Performance

Afya stock opened at $13.63 on Thursday. Afya Limited has a 52-week low of $13.00 and a 52-week high of $16.50. The firm has a market capitalization of $1.28 billion, a price-to-earnings ratio of 8.91, a PEG ratio of 1.38 and a beta of 0.34. The company has a fifty day simple moving average of $14.35 and a 200-day simple moving average of $14.43. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.42.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on AFYA shares. Weiss Ratings downgraded shares of Afya from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, July 31st. Bank of America restated a “neutral” rating on shares of Afya in a research report on Thursday, June 11th. Wall Street Zen cut Afya from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 2nd. JPMorgan Chase & Co. lowered their price target on Afya from $21.50 to $21.00 and set a “neutral” rating on the stock in a research report on Monday, June 22nd. Finally, Zacks Research lowered Afya from a “strong-buy” rating to a “hold” rating in a report on Wednesday, May 6th. Six research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $18.00.

Insider Activity

In related news, VP Gomiero Mirella Basolli sold 10,000 shares of the business’s stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $14.80, for a total transaction of $148,000.00. Following the transaction, the vice president directly owned 34,530 shares in the company, valued at approximately $511,044. The trade was a 22.46% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Lelio De Souza Junior sold 41,541 shares of the company’s stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $15.00, for a total transaction of $623,115.00. Following the sale, the vice president directly owned 36,204 shares of the company’s stock, valued at approximately $543,060. This represents a 53.43% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 87,745 shares of company stock worth $1,314,175. Insiders own 0.80% of the company’s stock.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.